Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorder

Clin Med Insights Pediatr. 2012 Nov 5;6:95-162. doi: 10.4137/CMPed.S7868. Print 2012.

Abstract

Several non-stimulant medications have been used in the treatment of attention deficit hyperactivity disorder (ADHD). Atomoxetine, was introduced in 2002. The safety and efficacy of atomoxetine in the treatment of ADHD for children, adolescents, and adults has been evaluated in over 4000 patients in randomized controlled studies and double blinded studies as well as in recent large longitudinal studies. This paper provides an updated summary of the literature on atomoxetine, particularly in relation to findings on the short- and long-term safety of atomoxetine in children and adolescents arising from recent large longitudinal cohort studies. Information is presented about the efficacy, safety, and tolerability of this medication.

Keywords: ADHD; adolescents; atomoxetine; children; efficacy; safety.